SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001214659-24-013191
Filing Date
2024-07-30
Accepted
2024-07-30 16:30:39
Documents
76
Period of Report
2024-04-30

Document Format Files

Seq Description Document Type Size
1 x71924010k.htm   iXBRL 10-K 1480430
2 EXHIBIT 4.4 ex4_4.htm EX-4.4 7477
3 EXHIBIT 23.1 ex23_1.htm EX-23.1 2914
4 EXHIBIT 23.2 ex23_2.htm EX-23.2 2925
5 EXHIBIT 31.1 ex31_1.htm EX-31.1 8712
6 EXHIBIT 31.2 ex31_2.htm EX-31.2 8640
7 EXHIBIT 32.1 ex32_1.htm EX-32.1 6447
8 EXHIBIT 97.1 ex97_1.htm EX-97.1 22045
14 GRAPHIC devpipline_v2.jpg GRAPHIC 171222
15 GRAPHIC alzlandscape.jpg GRAPHIC 92428
16 GRAPHIC patientpopulation.jpg GRAPHIC 58621
  Complete submission text file 0001214659-24-013191.txt   6641105

Data Files

Seq Description Document Type Size
9 XBRL SCHEMA FILE alzm-20240430.xsd EX-101.SCH 46549
10 XBRL CALCULATION FILE alzm-20240430_cal.xml EX-101.CAL 40901
11 XBRL DEFINITION FILE alzm-20240430_def.xml EX-101.DEF 183330
12 XBRL LABEL FILE alzm-20240430_lab.xml EX-101.LAB 369744
13 XBRL PRESENTATION FILE alzm-20240430_pre.xml EX-101.PRE 319684
78 EXTRACTED XBRL INSTANCE DOCUMENT x71924010k_htm.xml XML 644352
Mailing Address 3500 LENOX RD. NE SUITE 1500 ATLANTA GA 30326
Business Address 3500 LENOX RD. NE SUITE 1500 ATLANTA GA 30326 844-722-6333
Alzamend Neuro, Inc. (Filer) CIK: 0001677077 (see all company filings)

IRS No.: 811822909 | State of Incorp.: DE | Fiscal Year End: 0430
Type: 10-K | Act: 34 | File No.: 001-40483 | Film No.: 241157938
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)